Evolution of Genomic and T-cell Repertoire Heterogeneity of Malignant Pleural Mesothelioma Under Dasatinib Treatment.
Runzhe ChenWon-Chul LeeJunya FujimotoJun LiXin HuReza MehranDavid RiceStephen G SwisherBoris SepesiHai T TranChi-Wan ChowLatasha D LittleCurtis GumbsCara L HaymakerJohn Victor HeymachIgnacio I WistubaJiun-Kae Jack LeeP Andrew FutrealJianhua ZhangAlexandre ReubenAnne S TsaoJianjun ZhangPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2020)
Despite the homogeneous genomic landscape, the TCR repertoire is extremely heterogeneous in MPM. Dasatinib may potentially induce T-cell response leading to improved survival.